Every record from Janoshik · page 30
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020155 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.44 | 7.03 | 99.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019442 | Semaglutide | Homopeptide | HOMO-2511-G9197 | 2025-Q4 | 99.55 | 6.50 | 101.2 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-021098 | Semaglutide | WXT | WXT-2507-N4828 | 2025-Q4 | 97.43 | 4.81 | 107.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020605 | IGF-1 DES (1-3) | SSA | SSA-2509-Y7113 | 2025-Q4 | 97.65 | 6.48 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020438 | Tirzepatide | KP | KP-2506-B4700 | 2025-Q4 | 97.65 | 2.97 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020343 | BPC-157 | MKM | MKM-2506-D3139 | 2025-Q4 | 98.92 | 3.42 | 105.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020006 | Ipamorelin | ERP | ERP-2505-U6755 | 2025-Q4 | 99.93 | 4.40 | 89.6 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019569 | Semaglutide | Homopeptide | HOMO-2509-F1941 | 2025-Q4 | 99.62 | 4.70 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019390 | Retatrutide | Homopeptide | HOMO-2508-Y8363 | 2025-Q4 | 98.17 | 7.28 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018702 | GHRP-6 | QSC | QSC-2508-F6725 | 2025-Q4 | 99.93 | 4.60 | 89.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020909 | GHRP-6 | CPC | CPC-2507-G2066 | 2025-Q4 | 99.62 | 7.52 | 98.0 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019837 | IGF-1 LR3 | SWB | SWB-2510-U5063 | 2025-Q4 | 98.31 | 5.94 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019584 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | 2025-Q4 | 99.56 | 6.35 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019102 | BPC-157 | JEEP | JEEP-2505-J3812 | 2025-Q4 | 99.59 | 3.10 | 99.2 | Supplier-supplied | 0 | PASS |
| AX-2025-018778 | Tirzepatide | QSC | QSC-2511-S7989 | 2025-Q4 | 99.74 | 4.48 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018619 | Retatrutide | QYB | QYB-2507-R5467 | 2025-Q4 | 98.87 | 4.48 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018463 | Tirzepatide | WWB | WWB-2506-T2732 | 2025-Q4 | 99.81 | 3.68 | 91.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019169 | Semaglutide | TFC | TFC-2507-U5442 | 2025-Q4 | 99.42 | 3.96 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018807 | TB-500 | QSC | QSC-2507-J7717 | 2025-Q4 | 99.93 | 5.50 | 105.9 | Supplier-supplied | 0 | PASS |
| AX-2025-018448 | Melanotan II | WWB | WWB-2510-P2932 | 2025-Q4 | 99.71 | 4.68 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020314 | Semaglutide | MKM | MKM-2507-D3230 | 2025-Q4 | 99.00 | 4.63 | 93.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018596 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 98.76 | 4.53 | 106.7 | Supplier-supplied | 1 | FAIL |
| AX-2025-018451 | Melanotan II | WWB | WWB-2510-P2932 | 2025-Q4 | 99.08 | 5.32 | 99.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021072 | Semaglutide | WXT | WXT-2505-P4630 | 2025-Q4 | 98.95 | 5.27 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019721 | L-Glutathione (reduced) | HJ | HJ-2507-P3062 | 2025-Q4 | 98.83 | 6.96 | 92.6 | Supplier-supplied | 0 | PASS |
| AX-2025-021069 | Semaglutide | WXT | WXT-2505-P4630 | 2025-Q4 | 99.76 | 4.97 | 93.4 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020578 | PEG-MGF | SSA | SSA-2505-U6896 | 2025-Q4 | 95.55 | 3.57 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020451 | KPV | KP | KP-2509-N5148 | 2025-Q4 | 99.23 | 2.40 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020240 | MOTS-c | GGPeps | GGPE-2508-J1903 | 2025-Q4 | 99.40 | 4.44 | 104.9 | Supplier-supplied | 0 | PASS |
| AX-2025-018999 | PT-141 (Bremelanotide) | FGP | FGP-2509-H2645 | 2025-Q4 | 99.93 | 3.08 | 100.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018958 | PT-141 (Bremelanotide) | FGP | FGP-2505-K1249 | 2025-Q4 | 98.65 | 3.37 | 104.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020911 | GHRP-6 | CPC | CPC-2507-G2066 | 2025-Q4 | 99.63 | 6.53 | 89.5 | Supplier-supplied | 4 | MARGINAL |
| AX-2025-020872 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 97.41 | 5.61 | 98.4 | Buyer-sourced | 2 | FAIL |
| AX-2025-020443 | KPV | KP | KP-2509-N5148 | 2025-Q4 | 99.46 | 2.05 | 99.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020163 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.50 | 7.26 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018541 | Semax | WWB | WWB-2506-S4098 | 2025-Q4 | 99.89 | 8.82 | 99.5 | Supplier-supplied | 0 | PASS |
| AX-2025-020227 | Cagrilintide | GGPeps | GGPE-2507-Y1706 | 2025-Q4 | 97.76 | 0.93 | 91.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019045 | GHRP-2 | JEEP | JEEP-2508-S3268 | 2025-Q4 | 99.41 | 3.70 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021230 | AOD-9604 | BCH | BCH-2509-K6299 | 2025-Q4 | 98.03 | 5.16 | 89.4 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-021223 | BPC-157 | BCH | BCH-2508-H6138 | 2025-Q4 | 98.39 | 3.26 | — | Supplier-supplied | 2 | MARGINAL |